Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (13783)	6/3/2000 10:52:00 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Cacaito, such hatred for a company. You can't put a price on Neuprex. Now that is what I have said over and over again. Why do I care if Xoma floats some more shares when it has such a stake in Neuprex while Baxter pays the way? Do I love Neuprex and anti-Cd11a......you bet. Just like I love a company I can make money on either long or short term. Dangerous??? You bet. All Biotechs are risky and lately MOST IF NOT ALL investments in the market are more risky than ever. No sense kidding yourself about Neuprex. Best way in my opinion to play Neuprex for max performance is to play Xoma. If Neuprex gets approved WHO CARES IF XOMA HAS 100 MILLION SHARES OUTSTANDING?????? Check market cap of other companies in high tech and Biotechs which DON'T come close to having potential product like Neuprex. BTW, I argue with everyone including George and Bob. Also as you know I have been very critical of Xoma in certain areas recent evidence being asking release of data now.